Middle latency auditory-evoked potentials in myotonic dystrophy: Relation to the size of the CTG trinucleotide repeat and intelligent quotient

Journal of the Neurological Sciences

Volumn 207, Issue 1-2, 2003, Pages 31-36

  Arakawa, Kenji ^a,b,c   Tomi, Hideaki ^a   Tobimatsu, Shozo ^b   Kira, Jun Ichi ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c National Chikugo Hospital   (Japan)

Author keywords

CTG repeat; Middle latency auditory evoked potentials; Myotonic dystrophy; The central nervous system involvement

Indexed keywords

PROTEIN KINASE;

ADULT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; EVOKED AUDITORY RESPONSE; FEMALE; GENE; GENE AMPLIFICATION; HUMAN; INTELLIGENCE QUOTIENT; INTELLIGENCE TEST; LATENT PERIOD; MALE; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT; VALIDATION PROCESS;

ADULT; AGED; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; REACTION TIME; TRINUCLEOTIDE REPEATS;

EID: 12244311199     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00354-4     Document Type: Conference Paper

References (48)

1. Harper P.S. Myotonic dystrophy. 3rd ed. 2001;Saunders, London. Warlow C.P., Van Gijn J. editors. Major problems in neurology, vol. 37.
2. Bird T.B., Follet C., Griep E. Cognitive and personality function in myotonic muscular dystrophy. J. Neurol. Neurosurg. Psychiatry. 46:1983;971-980.
3. Glantz R.H., Wright R.B., Huckman M.S., Garron D.C., Siegel I.M. Central nervous system magnetic resonance imaging findings in myotonic dystrophy. Arch. Neurol. 45:1988;36-37.
4. Huber S.J., Kissel J.T., Shuttleworth E.C., Chakeres D.W., Clapp L.E., Brogan M.A. Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch. Neurol. 46:1989;536-540.
5. Perini G.I., Colombo G., Armani M.et al. Intellectual impairment and cognitive evoked potentials in myotonic dystrophy. J. Nerve. Ment. Dis. 177:1989;750-754.
6. Censori B., Danni M., Del Pesce M., Provinciali L. Neuropsychological profile in myotonic dystrophy. J. Neurol. 237:1990;251-256.
7. Ragazzoni A., Pinto F., Taiuti R., Silveri M.C. Myotonic dystrophy: an electrophysiological study of cognitive deficits. Can. J. Neurol. Sci. 18:1991;300-306.
8. Cosi V., Bergamaschi R., Versino M., Callieco R., Sandrini G., Ruiz L. Multimodal evoked potentials in myotonic dystrophy (MyD). Neurophysiol. Clin. 22:1992;41-50.
9. Fiorelli M., Duboc D., Mazoyer B.M.et al. Decreased cerebral glucose utilization in myotonic dystrophy. Neurology. 42:1992;91-94.
10. Chang L., Anderson T., Migneco O.A.et al. Cerebral abnormalities in myotonic dystrophy. Arch. Neurol. 50:1993;917-923.
11. Censori B., Provinciali L., Danni M.et al. Brain involvement in myotonic dystrophy: MRI features and their relationship to clinical and cognitive conditions. Acta Neurol. Scand. 90:1994;211-217.
12. Damian M.S., Schilling G., Bachmann G., Simon C., Stoppler S., Dorndorf W. White matter lesions and cognitive deficits: relevance of lesion pattern? Acta Neurol. Scand. 90:1994;430-436.
13. Turnpenny P., Clark C., Kelly K. Intelligence quotient profile in myotonic dystrophy, intergenerational deficit, and correlation with CTG amplification. J. Med. Genet. 31:1994;300-305.
14. Fierro B., Daniele O., Aloisio A.et al. Neurophysiological and radiological findings in myotonic dystrophy patients. Eur. J. Neurol. 5:1998;89-94.
15. Ono S., Takahashi K., Jinnai K.et al. Loss of catecholaminergic neurons in the medullary reticular formation in myotonic dystrophy. Neurology. 51:1998;1121-1124.
16. Ono S., Takahashi K., Jinnai K.et al. Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology. 50:1998;535-538.
17. Akiguchi I., Nakano S., Shiino A.et al. Brain proton magnetic resonance spectroscopy and brain atrophy in myotonic dystrophy. Arch. Neurol. 56:1999;325-330.
18. Meola G., Sansone V., Perani D.et al. Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology. 53:1999;1042-1050.
19. Oliveri M., Fierro B., Lo Presti R., Brighina F., La Bua V., Caimi G. P300 and respiratory findings in myotonic muscular dystrophy. Funct. Neurology. 14:1999;149-154.
20. Cacace A.T., Satya-Murti S., Wolpaw J.R. Human middle latency auditory evoked potentials: vertex and temporal components. Electroenceph. Clin. Neurophysiol. 77:1990;6-18.
21. Kaseda Y., Tobimatsu S., Morioka T., Kato M. Auditory middle-latency responses in patients with localized and non-localized lesions of the central nervous system. J. Neurol. 238:1991;427-432.
22. Onitsuka T., Ninomiya H., Sato E., Yamamoto T., Tashiro N. The effect of interstimulus intervals and between-block rests on the auditory evoked potential and magnetic field: is the auditory P50 in humans an overlapping potential? Clin. Neurophysiol. 111:2000;237-245.
23. Yvert B., Crouzeix A., Bertrand O., Annemarie S.-P., Pantev C. Multiple supratemporal sources of magnetic and electric auditory evoked middle latency components in humans. Cereb. Cortex. 11:2001;411-423.
24. Buchwald J.S., Erwin R.J., Van Lancker D., Cummings J.L. Midlatency auditory evoked responses: differential abnormality of P1 in Alzheimer's disease. Electroenceph. Clin. Neurophysiol. 74:1989;378-384.
25. Green J.B., Flagg L., Freed D.M., Schwankhaus J.D. The middle latency auditory evoked potential may be abnormal in dementia. Neurology. 42:1992;1034-1036.
26. Green J.B., Elder W.W., Freed D.M. The P1 component of the middle latency auditory evoked potential predicts a practice effect during clinical trials in Alzheimer's disease. Neurology. 45:1995;962-966.
27. Ogata A., Terae S., Fujita M., Tashiro K. Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study. Neuroradiology. 40:1998;411-415.
28. Deiber M.P., Ibañez V., Fischer C., Perrin F., Mauguière F. Sequential mapping favours the hypothesis of distinct generators for Na and Pa middle latency auditory evoked potentials. Electroenceph. Clin. Neurophysiol. 71:1988;187-197.
29. Brook J.D., McCurrach M.E., Harley H.G.et al. Molecular basis of myotonic dystrophy. Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding protein kinase family member. Cell. 68:1992;799-808.
30. Ashizawa T., Dunne C.J., Dubel J.R.et al. Anticipation in myotonic dystrophy: I. Statistical verification based on clinical and haplotype findings. Neurology. 42:1992;1871-1877.
31. Ashizawa T., Dubel J.R., Dunne P.W.et al. Anticipation in myotonic dystrophy: II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology. 42:1992;1877-1883.
32. Hunter A., Tsilfidis C., Mettler G.et al. The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J. Med. Genet. 29:1992;774-779.
33. Jaspert A., Fahsold R., Grehl H., Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J. Neurol. 242:1995;99-104.
34. Tokgozoglu L.S., Ashizawa T., Pacifico A., Armstrong R.M., Epstein H.F., Zoghbi W.A. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion. JAMA. 274:1995;813-819.
35. Gennarelli M., Novelli G., Andreasi Bassi F.et al. Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats. Am. J. Med. Genet. 65:1996;342-347.
36. Kinoshita M., Hirose K. Correlation between CTG triplet repeat length and the extent of multisystemic disorders in myotonic dystrophy. Nihon Rinsho. 57:1999;917-926.
37. Wechsler D. WAIS-R manual. 1981;Psychological Corporation, New York.
38. Jacobson G.P., Privitera M., Neils J.R., Grayson A.S., Yeh H.S. The effects of anterior temporal lobectomy (ATL) on the middle-latency auditory evoked potential (MLAEP). Electroenceph. Clin. Neurophysiol. 75:1990;230-241.
39. Woods D.L., Clayworth C.C. Age-related changes in human middle latency auditory evoked potentials. Electroenceph. Clin. Neurophysiol. 65:1986;297-303.
40. Buchwald J.S., Rubinstein E.H., Schwafel J., Strandburg R.J. Midlatency auditory evoked responses: differentials effects of a cholinergic agonist and antagonist. Electroenceph. Clin. Neurophysiol. 80:1991;303-309.
41. Park Y.D., Radtke R.A. Hypersomnolence in myotonic dystrophy. Neurology. 42(Suppl. 3):1992;352. [Abstract].
42. van der Meché F.G.A., Bogaard J.M., van der Sluys J.C.M.et al. Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J. Neurol. Neurosurg. Psychiatry. 57:1994;626-628.
43. Park Y.D., Radtke R.A. Hypersomnolence in myotonic dystrophy: demonstration of sleep onset REM sleep. J. Neurol. Neurosurg. Psychiatry. 58:1995;512-513. [Letter].
44. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science. 189:1975;55-58.
45. Silberman E.K., Vivaldi E., Garfield J., McCarley R.W., Hobson J.A. Carbacol triggering of desynchronized sleep phenomena: enhancement via small volume infusion. Brain Res. 191:1980;215-224.
46. Martorell L., Martinez J.M., Carey N., Johnson K., Baiget M. Comparison of CTG repeat length expansion and clinical progression of myotonic dystrophy over a five year period. J. Med. Genet. 32:1995;173.
47. Spranger M., Spranger S., Tischendorf M., Meinck H.-M., Cremer M. Myotonic dystrophy. The role of large triplet repeat length in the development of mental retardation. Arch. Neurol. 54:1997;251-254.
48. Martinello F., Piazza A., Pastorello E., Angelini C., Trevisan C.P. Clinical and neuroimaging study of central nervous system in congenital myotonic dystrophy. J. Neurol. 246:1999;186-192.